Release Date: 27/04/09 10:13 Summary: Substantial Shareholder Notices Price Sensitive: No Download Document 73.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%